PGK2 and lung carcinoma: Moreover, a peptide (AVVLMSHLGRPDGVPMPDK) supporting the detection of PGK2 was identified in all samples with high abundance (Fig. 4c), and the abundance in tumors was significantly higher than in adjacent normal tissues (p < 2.2e-16, two-sided Wilcoxon Rank Sum test, Fig. 4c-d), suggesting PGK2 as a possible cancer/testis (CT) antigen and a putative immunotherapy target for lung cancer treatment.